PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...

The government said medical data of 500,000 people was affected but no personally identifiable information had been made ...

DNA methylation data can be used to estimate biological age, but results across commercial tests differ, raising questions ...

Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.